About PANZYGA
PANZYGA is in a class of medicine called intravenous immunoglobulin (IVIg). PANZYGA is a liquid medicine for infusion that contains immunoglobulin G (IgG).
How is PANZYGA made?
PANZYGA is made from healthy human plasma.
Ig therapy like PANZYGA is made from human plasma, which is collected from healthy donors and may contain infectious agents. That's why Ig therapy is made under FDA guidelines, which include:
- Screening plasma donors for certain viruses and other diseases
- Testing the collected plasma to help ensure that it is virus and disease free
- Helping ensure certain viruses are inactivated or removed when PANZYGA is manufactured
Why PANZYGA?
Back to topWhy PANZYGA?
PANZYGA is FDA approved to treat people with chronic inflammatory demyelinating polyneuropathy (CIDP), chronic immune thrombocytopenia (cITP), or primary immunodeficiency (PI).
- For adults with CIDP, PANZYGA may help improve arm and leg strength and mobility
- For people 2 years of age and older with PI, PANZYGA helps replace antibodies that are missing from the immune system, which may help reduce the risk of infection
- For adults with cITP, PANZYGA helps boost platelet count, which may help control and prevent bleeding
PANZYGA infusions
Back to topPANZYGA is given as an infusion through a needle in a vein and is administered by a healthcare provider.
Your infusion will start at a slow rate. It may gradually increase if you tolerate it well. Your healthcare provider will monitor you during your infusion. They will be looking for signs of infusion reactions. These reactions can include headache, abdominal pain, fever, nausea, fatigue, vomiting, dizziness, and anemia. They may stop your PANZYGA treatment if you experience a reaction. Slowing or stopping the infusion may help these reactions to lessen or go away.
The infusion time for PANZYGA varies based on the condition (CIDP, PI, or cITP) being treated and the rate of infusion.
PANZYGA side effects
Back to topClick below to learn more about side effects for people with:
Please see the Important Safety Information for PANZYGA throughout this website for additional information on possible side effects.
Stay informed
Back to top
Learn more here. When you have questions, it’s best to talk with your healthcare team. In addition, please find some frequently asked questions and answers about PANZYGA treatment to help get you started.
Help with managing your condition. PANZYGA offers a variety of downloadable resources with information about treatment, including guides to keep track of your therapy, and more.
All in one place. Pfizer IGuide™ can help you understand your insurance coverage and out-of-pocket costs for your prescribed PANZYGA, as well as identify financial assistance options for which you may be eligible.
Learn more. A free mobile app designed to help support the treatment experience for patients.
Sign up for additional information to help you understand more about PANZYGA and to receive free resources.
Learn more here With this program, eligible patients may pay as little as $0 for PANZYGA*.
- Patients must have commercial insurance to be eligible
- Patients are not eligible if they are enrolled in a state or federally funded insurance program
*The PANZYGA Co-Pay Program provides eligible patients assistance of up to $12,500 per year or the cost of a patient’s co-pay in a 12-month period (whichever is less). The PANZYGA Co-Pay Program is good only in the U.S. and Puerto Rico. No membership fees. Federal and state health care beneficiaries are not eligible. Private insurance only. Eligibility and restrictions apply. See Terms and Conditions at http://pfizeriguide.com
